Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer

NCT00866905 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

168

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Ixabepilone
DRUG: Cyclophosphamide

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]